Consonance Capital Management LP / MYGN
Consonance Capital Management LP’s Myriad Genetics Inc Position
Does Consonance Capital Management LP own Myriad Genetics Inc (MYGN)? Not currently — the last reported position was 3.31M shares worth $110M in Q1 2019; the fund’s latest 13F (Q3 2022) no longer reports it.
Position Value
$110M
Q1 2019
Shares
3.31M
% of Portfolio
+6.94%
Quarters Held
1
position exited
Position History MYGN
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2019 | 3.31M | $110M | +6.94% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Consonance Capital Management LP’s full portfolio or all institutional holders of MYGN.